/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
TriState Capital Holdings, Inc. Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Depositary Shares
PITTSBURGH–(BUSINESS WIRE)–TriState Capital Holdings, Inc. (Nasdaq: TSC) (“TriState Capital”)
announced today that the underwriters of its recently closed public
offering of depositary shares, each representing a 1/40th interest in a
share of its 6.375% Fixed-to-Floating Rate Series B Non-Cumulative
Perpetual Preferred Stock, no par value (the “Series B Preferred
Stock”), have exercised in full their option to purchase an additional
420,000 depositary shares. The Series B Preferred Stock has a
liquidation preference of $1,000 per share (equivalent to $25 per
depositary share). The sale of the additional 420,000 depositary shares
resulted in additional net proceeds to the Company of approximately
$10.2 million before expenses.
TriState Capital expects to use the net proceeds from the offering for
general corporate purposes, potentially including repurchases of its
common stock, future acquisitions, its working capital needs and
investments in its subsidiaries.
Keefe, Bruyette & Woods, Inc., A Stifel Company, and Raymond
James & Associates, Inc. acted as joint book-running managers of the
offering. B. Riley FBR, Boenning & Scattergood, Inc. and Stephens Inc.
acted as co-managers of the offering.
A shelf registration statement, including a prospectus, with respect to
the offering was previously filed by TriState Capital with the
Securities and Exchange Commission (the “SEC”) and was declared
effective by the SEC on December 21, 2017. A prospectus supplement
relating to and describing the terms of the offering was filed and is
available on the SEC’s website at www.sec.gov.
Copies of the final prospectus supplement and the accompanying
prospectus relating to these securities may be obtained free of charge
by visiting the SEC’s website at www.sec.gov,
or may be obtained from Keefe, Bruyette & Woods, Inc., Attention: Equity
Capital Markets, 787 Seventh Avenue, 4th Floor, New York, NY 10019, by
calling (800) 966-1559 or by emailing [email protected]
or Raymond James & Associates, Inc., Attention: Equity Syndicate, 880
Carillon Parkway, St. Petersburg, Florida 33716, by calling 800-248-8863
or by emailing [email protected].
This press release shall not constitute an offer to sell, or the
solicitation of an offer to buy, any security, nor shall there be any
offer, solicitation or sale of these securities in any jurisdiction in
which such offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
jurisdiction.
ABOUT TRISTATE CAPITAL
TriState Capital Holdings, Inc. (Nasdaq: TSC) is a bank holding company
headquartered in Pittsburgh, Pa., providing commercial banking, private
banking and investment management services to middle-market companies,
institutional clients and high-net-worth individuals. Its TriState
Capital Bank subsidiary had $6.3 billion in assets, as of March 31,
2019, and serves middle-market commercial customers through regional
representative offices in Pittsburgh, Philadelphia, Cleveland, Edison,
N.J., and New York City, as well as high-net-worth individuals
nationwide through its national referral network of financial
intermediaries. Its Chartwell Investment Partners subsidiary had $9.7
billion in assets under management, as of March 31, 2019, and serves
institutional clients and TriState Capital’s financial intermediary
network.
FORWARD LOOKING STATEMENTS
This press release contains “forward-looking statements” in reliance on
the safe-harbor for such statements provided by the Private Securities
Litigation Reform Act of 1995. The words “achieve,” “anticipate,”
“believe,” “estimate,” “expect,” “intend,” “maintain,” “may,”
“opportunity,” “plan,” “potential,” “project,” “sustain,” “target,”
“trend,” or similar expressions, or future or conditional verbs such as
“will,” “would,” “should,” “could,” “may,” and similar expressions,
among others, generally identify forward-looking statements. Examples of
forward-looking statements include, without limitation, statements
relating to TriState Capital’s future plans, objectives or goals and are
based on current expectations, plans or forecasts, including with
respect to the anticipated use of proceeds. Such forward-looking
statements are subject to risks, uncertainties and changed circumstances
that are difficult to predict and are often beyond TriState Capital’s
ability to control.
Actual results or outcomes could differ materially from those currently
anticipated, discussed or projected by forward-looking statements. We
caution readers not to place undue reliance on any forward-looking
statements, which speak only as of the date on which they are made, and
TriState Capital disclaims any duty to revise or update any
forward-looking statement, whether written or oral, that may be made
from time to time by or on behalf of TriState Capital for any reason,
except as specifically required by law. Factors that could cause or
contribute to such differences include, but are not limited to: the
level of market volatility, our ability to execute our growth strategy,
including the availability of future bank acquisition opportunities, our
ability to execute on our revenue and efficiency improvement
initiatives, unanticipated losses related to the completion and
integration of mergers and acquisitions, and other factors and risk
influences contained in our most-recent annual and quarterly reports
filed on Form 10-K and Form 10-Q, and under the heading “Risk Factors”
in the preliminary prospectus supplement filed in connection with the
offering and other documents we file with the Securities and Exchange
Commission from time to time.
Contacts
MEDIA
Jack Horner
Hornercom
267-932-8760, ext. 302
412-600-2295
(mobile)
[email protected]
INVESTORS
Jeff Schoenborn and Kate Croft
Casteel
Schoenborn
888-609-8351
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis7 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa